NeuroDx
New York, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $165M
Overview
An AI-driven digital diagnostics platform for objective, early detection and monitoring of neurological disorders.
NeuroscienceDiagnostics
Technology Platform
An AI-powered platform that analyzes multimodal digital biomarkers (e.g., speech, motor function) from consumer-grade devices to create objective diagnostic and monitoring tools for neurological diseases.
Funding History
1Total raised:$165M
Series A$165M
Opportunities
Large addressable market due to aging populations and high unmet need for objective, early neurological diagnostics.
Risk Factors
Regulatory hurdles for software as a medical device and the challenge of clinically validating AI algorithms across diverse patient cohorts.
Competitive Landscape
Competes with other digital neurology firms like Altoida and Biofourmis in a crowded but rapidly growing market for remote patient monitoring and digital biomarkers.